Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome.
Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment. Other features of this syndrome gradually develop. We describe three TRMA patients with heart rhythm abnormalities and structural cardiac anomalies. Eight other reported TRMA patients also had cardiac anomalies. Recently, the TRMA gene, SLC19A2, was identified, encoding a functional thiamine transporter. Characterization of the metabolic defect of TRMA may shed light on the role of thiamine in common cardiac abnormalities.
Lorber
A
A
Department of Pediatric Cardiology, Rambam Medical Center, PO Box 9602, Haifa 31096, Israel.
Gazit
A Z
AZ
Khoury
A
A
Schwartz
Y
Y
Mandel
H
H
D000293:Adolescent; D000749:Anemia, Megaloblastic / Q000150:complications* / Q000188:drug therapy; D002648:Child; D006331:Heart Diseases / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D013577:Syndrome; D013831:Thiamine / Q000627:therapeutic use*
D013831:Thiamine